DOCS vs WAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

DOCS

58.0
AI Score
VS
DOCS Wins

WAY

41.7
AI Score

Investment Advisor Scores

DOCS

58score
Recommendation
HOLD

WAY

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric DOCS WAY Winner
Revenue 156.62M 633.55M WAY
Net Income 24.32M 84.15M WAY
Net Margin 15.5% 13.3% DOCS
Operating Income 33.64M 156.51M WAY
ROE 2.7% 2.1% DOCS
ROA 2.2% 1.4% DOCS
Total Assets 1.08B 5.87B WAY
Cash 273.60M 12.64M DOCS
Current Ratio 6.08 1.85 DOCS

Relative Price Performance (Last 90 Days)

DOCS 1M: +2.4% · 3M: +27.8% WAY 1M: -4.4% · 3M: +27.2%

Current Technical Phase

DOCS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (9.2% over 20 days), RSI 54

RSI (14): 53.7 · Price: $25.58

WAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 43.8 · Price: $23.47

Fundamentals Snapshot

Metric DOCS WAY
Market Cap
Forward P/E 15.8 12.5
Trailing P/E 28.7 33.9
Revenue (TTM)
Revenue Growth 0.1% 0.2%
Gross Margin 0.9% 0.7%
Operating Margin 0.2% 0.2%
EPS 0.86 0.68
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, DOCS is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.